If this test-marketing is agreed to be successful by both parties Tagerr will then be made ReGen’s exclusive distributor for Poland subject to Tagerr being able to secure the necessary regulatory and import approvals.
ReGen said that, to date, Colostrinin is marketed in the US, Canada and Australia under the brand name CogniSure and in Cyprus under the brand name Cognase as a nutritional supplement to ‘support healthy brain aging and cognition in humans’.
Percy Lomax, chairman and CEO of ReGen, said: “The agreement in Poland marks an important step in the accelerated rollout program for Colostrinin. Poland is the country where Colostrinin was first discovered and we know from the internet that there is significant knowledge of the product in Poland. As such both Tagerr and ourselves are optimistic that sales here will be significant.”